Gene Therapy Biopharma uniQure Sets Terms For $64 Million IPO
Published: Jan 27, 2014
uniQure, which develops gene therapies for the treatment of orphan diseases, announced terms for its IPO on Friday. The Amsterdam, Netherlands-based company plans to raise $64 million by offering 4.6 million shares at a price range of $13 to $15. At the midpoint of the proposed range, uniQure would command a market value of $235 million.
Help employers find you! Check out all the jobs and post your resume.